Effect of Vitamin D Serum Levels and Supplementation on Atopic Dermatitis: A Systematic Review and Meta-analysis Jing Chun NgYik Weng Yew Systematic Review 05 March 2022 Pages: 267 - 275
Cutaneous Manifestations of SARS-CoV-2 Infection Thy HuynhXavier Sanchez-FloresJennifer T. Huang Review Article 05 March 2022 Pages: 277 - 286
Economic Burden of Chronic Hand Eczema: A Review April ArmstrongJulie Hahn-PedersenJacob P. Thyssen Review Article Open access 08 March 2022 Pages: 287 - 300
New Practical Aspects of Sweet Syndrome Tejas P. JoshiSarah K. FriskeMadeleine Duvic Review Article 14 February 2022 Pages: 301 - 318
Patient and Public Involvement in Dermatology Research: A Review Megan HeagueChandrima RayAlison Layton Review Article 29 March 2022 Pages: 319 - 329
Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma Francesca AroldiMark R. Middleton Review Article 31 March 2022 Pages: 331 - 338
A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions Laura Del RegnoSilvia CatapanoKetty Peris Review Article Open access 19 February 2022 Pages: 339 - 352
Correction to: A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions Laura Del RegnoSilvia CatapanoKetty Peris Correction Open access 22 April 2022 Pages: 353 - 353
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis Robert BissonnetteRobert S. CallMark Lee Original Research Article Open access 04 April 2022 Pages: 355 - 364
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE) Andrew BlauveltEmma Guttman-YasskyAshish Bansal Original Research Article Open access 14 May 2022 Pages: 365 - 383
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study Khalaf KridinYochai SchonmannArnon D. Cohen Original Research Article Open access 16 March 2022 Pages: 385 - 392
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis Lisa A. BeckMette DeleuranArsalan Shabbir Original Research Article Open access 03 May 2022 Pages: 393 - 408
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis Sheridan M. Hoy Adis Drug Evaluation Open access 03 May 2022 Pages: 409 - 420
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials Shari R. LipnerJulianne M. Falotico Research Letter 10 April 2022 Pages: 421 - 424
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma Ellen J. KimJoan GuitartLarisa J. Geskin Correction 15 March 2022 Pages: 425 - 425